Dyno Therapeutics is a Cambridge based, VC-backed biotech startup that uses next-gen DNA technologies and machine learning to engineer Adeno-associated Virus (AAV) capsids for effective delivery of gene therapies.

Biotechnology

Education

Dyno Therapeutics

Dyno Therapeutics' headquarters in Cambridge, MA, United States

Eric Kelsic

Sam Sinai

Russ Katz

Rebecca Servais

Tyson Bertmaring

Kosta Kleitsas

Yvette Leung

Tomas Bjorklund

Debora S. Marks

Alan Crane

Adrian Veres

George Church

The Scientist Team at Dyno Therapeutics is responsible for leveraging advanced DNA technologies, computational science, deep learning, and experimental biology to engineer Adeno-associated Virus (AAV) capsids. Their work involves designing, testing, and refining new AAV variants to enhance the delivery and efficacy of gene therapies. This multidisciplinary team combines computational modeling and lab-based experiments to push the boundaries of gene therapy delivery systems.

Scientist Team

The Leadership Team at Dyno Therapeutics drives the strategic direction and vision of the company, leveraging their diverse expertise in experimental science, deep learning, business development, and talent management. They collaborate to foster innovation in gene therapy delivery through cutting-edge AAV capsid engineering, ensuring alignment of research initiatives with business goals and maintaining a strong organizational culture. Their collective experience and leadership are pivotal in navigating the complexities of the biotech landscape and securing funding for future advancements.

Leadership Team

The Experimental Science team at Dyno Therapeutics focuses on designing, conducting, and analyzing laboratory experiments to advance the engineering of Adeno-associated Virus (AAV) capsids. Utilizing next-gen DNA technologies and machine learning, they aim to optimize gene therapy delivery systems, driving innovation and efficacy in treatments.

Experimental Science

The Experimental Science Team at Dyno Therapeutics conducts cutting-edge research to develop and optimize Adeno-associated Virus (AAV) capsids using next-gen DNA technologies and machine learning. Their goal is to enhance the delivery methods for gene therapies, ensuring more effective and targeted treatments.

Experimental Science Team

The Scientific and Engineering Team at Dyno Therapeutics leverages advanced DNA technologies and deep learning algorithms to design and optimize Adeno-associated Virus (AAV) capsids for gene therapy applications. This team collaborates on cutting-edge research and development to enhance the precision and efficacy of gene delivery, supporting the company's mission to revolutionize treatments for genetic disorders.

Scientific and Engineering Team

The People and Talent Acquisition team at Dyno Therapeutics focuses on identifying, attracting, and retaining top talent to drive the company's innovative gene therapy initiatives. By leveraging cutting-edge recruitment strategies and fostering a supportive work culture, they ensure that Dyno Therapeutics has the skilled professionals needed to advance its mission of engineering advanced AAV capsids.

Dyno Therapeutics

Org chart

Board & advisors

Teams

Scientist Team

Leadership Team

Experimental Science

Experimental Science Team

Scientific and Engineering Team

People and Talent Acquisition

Offices

Dyno Therapeutics

Org chart

Board & advisors

Teams

Scientist Team

Leadership Team

Experimental Science

Experimental Science Team

Scientific and Engineering Team

People and Talent Acquisition

Offices

Related companies